Deramiocel BLA for Duchenne muscular dystrophy under U.S. FDA review with PDUFA target action date of August 22, 2026Pivotal HOPE-3 Phase 3 trial ...
Reports further stated the deadly strike was a result of a targeting mistake due to the U.S. military using outdated data provided by the Defense Intelligence Agency. Speaking at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results